0 POSTS 0 COMMENTSExecutive Vice President – Corporate Development, is responsible for leading Recipharm’s merger and acquisition (M&A) activities. He also leads Recipharm’s external and internal communications activities. With over 20 years of experience in the pharmaceutical contract development and manufacturing industry in supply chain and business development roles Mark also holds an MBA.
Maxwellia has expanded their team of switch experts with two new appointments following their relocation to the Alderley Park Accelerator.
BMS & Boston Medical Center enter research collaboration to investigate markers of immuno-oncology response and resistance Bristol-Myers Squibb Company...